The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Roche
Interim results of PEANUT: pembrolizumab and nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC).
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - AstraZeneca; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)
 
Daniele Raggi
No Relationships to Disclose
 
Marco Bandini
No Relationships to Disclose
 
Elena Farè
No Relationships to Disclose
 
Patrizia Giannatempo
No Relationships to Disclose
 
Maurizio Colecchia
No Relationships to Disclose
 
Filippo Pederzoli
No Relationships to Disclose
 
Andrea Gallina
No Relationships to Disclose
 
Laura Marandino
No Relationships to Disclose
 
Giuseppina Calareso
No Relationships to Disclose
 
Russell Madison
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Alberto Briganti
Consulting or Advisory Role - Astellas Pharma; Ferring; Janssen-Cilag; MDxHealth; OPKO Health
Research Funding - Sandoz-Novartis
 
Jeffrey S. Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Research Funding - Foundation Medicine
 
Francesco Montorsi
No Relationships to Disclose